8-K: Flora Growth Secures $25M Equity Line with White Lion Capital

Flora Growth Corp. has entered into an agreement with White Lion Capital, LLC for up to $25 million in common share purchases to fund its digital asset strategy and general corporate purposes.

Summary

• Flora Growth Corp. (FLGC) has secured an equity line of credit with White Lion Capital, LLC, allowing the company to sell up to $25 million of its common shares over 24 months.
• The commitment can be increased to an aggregate of $50 million at Flora Growth's discretion upon written notice to the investor.
• Shares will be purchased at a discount to market price, specifically 97% of the lowest daily VWAP over two consecutive business days for regular purchases, or the lowest traded price on the notice date (or 97% of lowest traded price two hours following acceptance) for rapid purchases.
• Proceeds are primarily intended for the company's digital asset treasury strategy, focusing on the $0G token, and for general corporate purposes.
• A commitment fee of $125,000 in common shares (0.5% of the initial commitment) will be paid to White Lion Capital upon the effectiveness of a resale registration statement.

Sentiment

Score: 6

Explanation: The filing indicates a successful capital raise, providing the company with flexible funding for its strategic initiatives, particularly in the digital asset space. However, the dilution risk for existing shareholders and the speculative nature of the digital asset market temper the overall positive sentiment. The ongoing litigation, though seemingly managed, adds a minor layer of uncertainty.

Positives

• Secures up to $25 million in capital, with potential for $50 million, providing flexible funding for operations and strategic initiatives without immediate upfront costs.
• The 'at-the-market' nature of the facility allows the company to draw capital as needed, potentially minimizing immediate dilution compared to a large, fixed-price offering.
• The capital is earmarked for advancing the digital asset treasury strategy, specifically the $0G token, which could be a growth area for the company.

Negatives

• The sale of common shares at a discount (97% of VWAP or lowest traded price) will result in dilution for existing shareholders.
• The actual number of shares issued and the effective price will depend on future market conditions and the company's stock price, introducing uncertainty regarding the total capital raised and dilution.
• A commitment fee of $125,000 in common shares is payable to the investor, further contributing to dilution.
• The company is prohibited from entering into other 'equity line' or substantially similar transactions during the commitment period without investor consent, limiting financing flexibility.

Risks

• Dilution Risk: The issuance of common shares to White Lion Capital will dilute the ownership of existing shareholders.
• Market Price Volatility: The actual proceeds received by the company will depend on the trading price of its common shares, which can be volatile, potentially leading to less capital raised than anticipated for a given level of dilution.
• Regulatory Compliance: The company must maintain compliance with NASDAQ listing rules, including a 19.99% share cap on issuances without shareholder approval, unless a minimum average price of $7.54 is met.
• Litigation Risk: Two pending actions claim the company is obligated to issue 500,000 and 1,500,000 common shares (pre-August 2025 consolidation) for alleged consulting services, though the company expects dismissal.
• Lease Breach Litigation: A civil case for $436,023.97 plus interest and legal fees for breach of lease and written guaranty agreement, with the company believing loss is probable and already reflected in financial statements.
• Digital Asset Strategy Risk: Investment in the $0G token and digital asset treasury strategy carries inherent risks associated with cryptocurrency and blockchain markets, which are highly volatile, speculative, and subject to evolving regulatory landscapes.
• No Guarantee of Funding: The company has the right, but not the obligation, to direct the investor to purchase shares, and it is possible that no shares will be issued under the Purchase Agreement.

Future Outlook

The company expects that any proceeds received from the share sales will primarily be used to advance its digital asset treasury strategy, with a specific focus on the $0G token, and for general corporate purposes. It is possible that no shares will be issued under the Purchase Agreement.

Management Comments

• "The Company expects that any proceeds received by the Company from such sales to the Investor will primarily be used to advance the Company's digital asset treasury strategy with a focus on the $0G token and for general corporate purposes."
• "It is possible that no shares will be issued under the Purchase Agreement."
• Regarding two legal actions for alleged consulting services: "The Company expects to file a motion to dismiss the case as the plaintiffs have not appeared or responded to communications. The earliest this motion can be heard is on November 12, 2025 and the Company expects the case to be dismissed at that point."
• Regarding the breach of lease claim: "The Company believes the likelihood of loss is probable and the loss can be reliably estimated. Please note that the full liability in relation to this case has already been reflected in the financial statements of the Company as the Company remains a guarantor on this lease."

Industry Context

This equity line facility provides Flora Growth Corp. with flexible access to capital, a common financing mechanism for growth-oriented companies, particularly those in emerging or capital-intensive sectors. The explicit focus on a 'digital asset treasury strategy' and the '$0G token' indicates a strategic pivot or expansion into the rapidly evolving and often volatile cryptocurrency and blockchain space, which carries both high potential rewards and significant risks compared to traditional industries.

Comparison to Industry Standards

• The discount rate for share purchases (97% of VWAP or lowest traded price) is within the standard range for equity line facilities, reflecting the liquidity premium for the investor.
• The 19.99% Exchange Cap on share issuances without shareholder approval is a common NASDAQ requirement designed to protect existing shareholders from excessive dilution.
• The beneficial ownership limitation of 4.99% (or 9.99% with notice) is standard to avoid triggering certain regulatory reporting requirements for the investor.
• The prohibition on other 'equity line' transactions without investor consent is typical for such agreements to ensure the investor remains the primary source of this type of financing.

Legal Proceedings

• Maria Beatriz Fernandez Otero and Sara Cristina Jacome De Torres brought an action against the Company claiming an obligation to issue 500,000 Common Shares (pre-August 2025 share consolidation) each for $0.05 per share for alleged consulting services. The Company expects to file a motion to dismiss as plaintiffs have not appeared or responded, with the earliest hearing having been on November 12, 2025.
• Ramon Ricardo Castellanos Saenz and Miriam Ortiz brought an action against the Company claiming an obligation to issue 1,500,000 common shares (pre-August 2025 share consolidation) each for $0.05 per share for alleged consulting services. The Company expects to file a motion to dismiss as plaintiffs have not appeared or responded, with the earliest hearing having been on November 12, 2025.
• On June 2, 2025, Vessel Brand, Inc., and Flora Growth Corp. were served in the Superior Court of California for breach of lease and written guaranty agreement in a civil case for $436,023.97 plus interest and legal fees. The Company believes the likelihood of loss is probable and estimable, and the full liability has already been reflected in its financial statements as a guarantor on the lease.

Stakeholder Impact

• Shareholders: Potential for significant dilution due to the issuance of new common shares at a discount to market price. The 19.99% cap without shareholder approval offers some protection, but further dilution is possible with approval or if the stock price meets the minimum threshold.
• Creditors: The capital raise could improve the company's liquidity and financial stability, potentially reducing credit risk.

Next Steps

• The Company must file a resale registration statement (Form S-1) with the SEC within 20 business days of November 28, 2025.
• The Company will use commercially reasonable efforts to have the registration statement declared effective as soon as practicable.
• The Company expects to file motions to dismiss two legal actions claiming share obligations, with the earliest hearing having been on November 12, 2025.
• The Company will continue to manage the breach of lease litigation, for which liability is already reflected in financial statements.
• The Company plans to utilize proceeds to advance its digital asset treasury strategy, focusing on the $0G token, and for general corporate purposes.

Key Dates

Recommendation

The equity line provides Flora Growth with much-needed capital flexibility, which is a positive for its strategic initiatives, especially the digital asset treasury strategy. However, the inherent dilution from selling shares at a discount and the speculative nature of the $0G token market introduce significant risk. While the company is addressing existing litigation, the overall financial health and the success of its new digital asset focus remain uncertain. Investors should hold to observe the execution of the digital asset strategy and the impact of future share issuances on valuation and dilution before making further investment decisions.

Keywords

Flora Growth Corp., FLGC, Equity Line, Share Purchase Agreement, White Lion Capital, Capital Raise, Dilution, Digital Asset Strategy, $0G Token, SEC Filing, 8-K, Common Shares, NASDAQ, Corporate Finance, Investment